8V2-26238-38327
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 028 / RI
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-05
Registered in v-safe
-
2021-03-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-03-08
Survey response — days 1–6 daily, dose 1MedDRA: Pain, Uterine dilation and curettage — Feeling: Good · Abdominal painFree text: Had a D&C today so that was the pain. All is wellMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-09
- 2021-03-11
- 2021-03-18
-
2021-03-25
Dose 2 — Pfizer-BioNTech
- 2021-03-30
- 2021-04-01
- 2021-04-16
- 2021-04-22
- 2021-05-02
- 2021-05-08
- 2021-06-26
- 2021-09-24
- 2022-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-25 | Pfizer-BioNTech |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Had a D&C today so that was the pain. All is well
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Uterine dilation and curettage | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release